Atreca

Fierce Biotech Layoff Tracker 2023: Bayer-bought BlueRock makes cuts; Alaunos lets go 60% of teams
Fierce Biotech Layoff Tracker 2023: Bayer-bought BlueRock makes cuts; Alaunos lets go 60% of teams
Fierce Biotech
layoffs
Alaunos Therapeutics
BlueRock Therapeutics
Thermo Fisher
Bristol Myers Squibb
Atreca
Galera Therapeutics
Inovio
Salarius Pharmaceuticals
Karyopharm Therapeutics
Intergalatic Therapeutics
Flag link:
Former Big Pharma darling Atreca axes lead drug, 40% of staff in last-ditch pivot to ADCs
Former Big Pharma darling Atreca axes lead drug, 40% of staff in last-ditch pivot to ADCs
Fierce Biotech
Atreca
antibody-drug conjugate
layoffs
Flag link:
Back to business for biotech flotations
Back to business for biotech flotations
EP Vantage
IPOs
BridgeBio
Turning Point Therapeutics
Stoke Therapeutics
Prevail Therapeutics
Atreca
NGM Biopharmaceuticals
Akero Therapeutics
Milestone Pharmaceuticals
Morphic Therapeutics
Karuna
Flag link:
Four More Through the IPO Door as Life Science Firms Raise $465M
Four More Through the IPO Door as Life Science Firms Raise $465M
Xconomy
IPOs
Personalis
Akero Therapeutics
Prevail Therapeutics
Atreca
Flag link:
The Week Ahead In Biotech: Conferences, PDUFA Dates Clinical Trial Readouts And IPOs
The Week Ahead In Biotech: Conferences, PDUFA Dates Clinical Trial Readouts And IPOs
Yahoo/Benzinga
FDA
Merck
Arqule
Affimed
BeiGene
Epizyme
MorphoSys
Theravance
Allena Pharma
Akero Therapeutics
Atreca
Dermavant Sciences
Personalis
Prevail Therapeutics
Stoke Therapeutics
IPOs
Flag link:
New IPO filings include BridgeBio, Dermavant, Prevail, Atreca, Akero
New IPO filings include BridgeBio, Dermavant, Prevail, Atreca, Akero
BioCentury
IPOs
BridgeBio
Dermavant
Prevail Therapeutics
Atreca
Akero Therapeutics
Flag link:
GSK, Gates Foundation help immuno-oncology player to $56M Series A round
GSK, Gates Foundation help immuno-oncology player to $56M Series A round
Fierce Biotech
GSK
Bill Gates
immuno-oncology
Atreca
Flag link: